(Q38061191)

28 August 2017

1 reference

title

HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality (English)

1 reference

28 August 2017

0 references

Ivan Stratov

3

0 references

Vijaya Madhavi

object named as

Vijaya Madhavi

series ordinal

1

0 references

Stephen J. Kent

object named as

Stephen J Kent

series ordinal

2

0 references

publication date

1 November 2012

1 reference

Expert Review of Clinical Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

8

1 reference

28 August 2017

page(s)

767-774

1 reference

HIV-1 prophylactic vaccine trials in Thailand

28 August 2017

cites work

1 reference

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

21 January 2018

1 reference

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

21 January 2018

1 reference

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

21 January 2018

1 reference

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

21 January 2018

1 reference

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

21 January 2018

1 reference

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

21 January 2018

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

21 January 2018

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

Public health. A sound rationale needed for phase III HIV-1 vaccine trials

21 January 2018

1 reference

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

21 January 2018

1 reference

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses

21 January 2018

1 reference

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

21 January 2018

1 reference

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

21 January 2018

1 reference

Moving ahead an HIV vaccine: to neutralize or not, a key HIV vaccine question

21 January 2018

1 reference

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

Activation of NK cells by ADCC responses during early HIV infection

21 January 2018

1 reference

Activation of NK cells by ADCC antibodies and HIV disease progression

21 January 2018

1 reference

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells

21 January 2018

1 reference

Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses

21 January 2018

1 reference

Quantitative 3D video microscopy of HIV transfer across T cell virological synapses

21 January 2018

1 reference

Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition

21 January 2018

1 reference

Rapid degranulation of NK cells following activation by HIV-specific antibodies.

21 January 2018

1 reference

Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects

21 January 2018

1 reference

NK cell function in HIV-1 infection

21 January 2018

1 reference

HIV-1 adaptation to NK-cell-mediated immune pressure

21 January 2018

1 reference

Humoral immunity to HIV-1: neutralisation and antibody effector functions

21 January 2018

1 reference

Female genital tract immunity: distinct immunological challenges for vaccine development

21 January 2018

1 reference

Cell-mediated immunity to HIV in the female reproductive tract

21 January 2018

1 reference

Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection

21 January 2018

1 reference

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

21 January 2018

1 reference

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

21 January 2018

1 reference

A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity

21 January 2018

1 reference

A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques

21 January 2018

1 reference

Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women

21 January 2018

1 reference

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads

21 January 2018

1 reference

Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.

21 January 2018

1 reference

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

21 January 2018

1 reference

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

21 January 2018

1 reference

Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.

21 January 2018

1 reference

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions

21 January 2018

1 reference

In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity

21 January 2018

1 reference

Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells

21 January 2018

1 reference

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

21 January 2018

1 reference

A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals

21 January 2018

1 reference

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

21 January 2018

1 reference

Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques

21 January 2018

1 reference

Disappointing data scuttle plans for large-scale AIDS vaccine trial

21 January 2018

1 reference

Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.74

1 reference

28 August 2017

1 reference